Ciproeptadine

Ciproeptadine is an anti-allergy medication that is used to decrease the symptoms of an allergic reaction such as dripping nose and septum, for example. However, it can also be used as an appetite stimulator, increasing the desire to eat.

This medicinal product for oral use in the form of tablets or syrup should only be used for medical reasons and may be purchased in conventional pharmacies under the trade names Cobavital or Apevitin, for example.

Price of Ciproeptadina

Ciproeptadine costs on average 15 reais, and may vary with the region and the form of the medicine.

Indications of Ciproeptadine

Ciproeptadine is used to relieve allergy symptoms caused by allergic rhinitis or allergic conjunctivitis associated with a common cold and concealer and red spots on the skin.

In addition, it can also be used as an appetite stimulant to increase weight.

How to use Ciproeptadine

Ciproeptadine should be taken orally with food, milk or water to reduce stomach irritation, usually at night.

Usually the doctor indicates for adults 4 mg every 6 to 8 hours as needed, about 3 to 4 times a day, with the maximum dose being up to 0.5 mg of weight per day;

In children, the doctor recommends the doses according to the age of the child, being that:

• between 7 and 14 years : administer 4 mg of Ciproeptadine 2 or 3 times a day. The maximum dose is 16 mg per day.
• between 2 and 6 years : administer 2 mg of Ciproeptadine 2 or 3 times a day. The maximum dose is 12 mg per day.

Side Effects of Ciproeptadine

In the elderly it is more common that the patient develops drowsiness, nausea and dryness in the mouth, nose or throat. However, nightmares, unusual excitement, nervousness, and irritability may occur in children.

Contraindications of Ciproeptadine

Ciproeptadine is contraindicated in patients with glaucoma, risk of urinary retention, patients with stomach ulcer, prostatic hypertrophy, bladder obstruction, asthma attacks, and hypersensitivity to any component of the formula.

In addition, it should not be used by pregnant women, breast-feeding, and in patients taking MAOIs within 14 days prior to initiation of MAOI treatment.